Sigachi begins construction work for MCC capacity expansion at Dahej
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
NEIAFMR to be developed as the national hub for folk medicine
Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine
For the full year, standalone gross revenue crossed Rs. 1,700 crore
Revenue from operations climbed 13% to Rs. 886.87 crore
Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum
The 38% adjusted EBITDA margin of base business has been supported by robust growth in the CDMO segment
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
Subscribe To Our Newsletter & Stay Updated